# US 2010/0166729 A9 · Modified factor VII polypeptides and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0166729 A9
- Document ID: US20100166729A9
- Status: Published application
- Kind: A9
- Application number: 12/082,662
- Filed: 2008-04-11
- Published: 2010-07-01
- Earliest claimed: 2007-04-13
- Inventors: Edwin L. Madison; Christopher Thanos; Sandra Waugh Ruggles; Shaun Coughlin
- Web page: https://patentgrep.com/patent/US20100166729A9

## CPC

- C07K 14/745: Blood coagulation or fibrinolysis factors
- A61K 38/36: Blood coagulation or fibrinolysis factors
- A61K 45/06: Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A61P 1/04: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A61P 13/10: of the bladder
- A61P 19/02: for joint disorders, e.g. arthritis, arthrosis
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Modified factor VII polypeptides and uses thereof are provided. Such modified FVII polypeptides include Factor VIIa and other forms of Factor VII. Among modified FVII polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.

## Claims

### Claim 1

A modified factor VII (FVII) polypeptide, comprising a modification in a FVII polypeptide, allelic and species variant thereof or active fragments thereof; wherein
the modification is at a position corresponding to position D196, K197 or K199 in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3 or in corresponding residues in a FVII polypeptide; and
the modification is replacement by a hydrophobic or acidic amino acid, wherein
the hydrophobic or acidic amino acid is selected from among Val (V), Leu (L), Ile (I), Phe (F), Trp (W), Met (M), Tyr (Y), Cys (C), Asp (D) and Glu (E).

### Claim 2 (depends on 1)

The modified FVII polypeptide of claim 1, wherein the modification in a FVII polypeptide is selected from among D196F, D196W, D196L, D196I, K197E, K197D, K197L, K197M, K197I, K197V, K197F, K197W, K199D and K199E.

### Claim 3 (depends on 2)

The modified FVII polypeptide of claim 2, wherein the modification in a FVII polypeptide is D196Y or K197Y.

### Claim 4 (depends on 1)

The modified FVII polypeptide of claim 1, further comprising a further modification at another position in the FVII polypeptide.

### Claim 5 (depends on 4)

The modified FVII polypeptide of claim 4, wherein the further modification is an amino acid replacement, insertion or deletion.

### Claim 6 (depends on 4)

The modified FVII polypeptide of claim 4, wherein the further modification is an amino acid replacement or insertion at a position corresponding to a position selected from among D196, K197, K199, G237, T239, R290 and K341, wherein the first modification and second modification are at different amino acids.

### Claim 7 (depends on 4)

The modified FVII polypeptide of claim 4, wherein the further amino acid modification is selected from among D 196K, D196R, D196A, D196Y, D196F, D196W, D196L, D196I, K197Y, K197A, K197E, K197D, K197L, K197M, K197I, K197V, K197F, K197W, K199A, K199D, K199E, G237W, G237T, G237I, G237V, T239A, R290A, R290E, R290D, R290N, R290Q, R290K, K341E, K341R, K341N, K341M, K341D and K341Q

### Claim 8 (depends on 5)

The modified FVII polypeptide of claim 5, wherein the further modification is an amino acid insertion selected from among G237T238insA, G237T238insS, G237T238insV, G237T238insAS, G237T238insSA, D196K197insK, D196K197insR, D196K197insY, D196K197insW, D196K197insA, D196K197insM, K1971198insE, K1971198insY, K1971198insA and K1971198insS.

### Claim 9 (depends on 4)

The modified FVII polypeptide claim 4, comprising modifications selected from among D196R/K197E/K199E, D196K/K197E/K199E, D196R/K197E/K199E/R290E, D196R/K197M/K199E, D196R/K197M/K199E/R290E, D196K/K197L, D196F/K197L, D196L/K197L, D196M/K197L, D196W/K197L, D196F/K197E, D196W/K197E, K196V/K197E, K197E/K341Q, K197L/K341Q, K197E/G237V/K341Q, K197E/K199E, K197E/G237V, K199E/K341Q and K197E/K199E/K341Q.

### Claim 10 (depends on 1)

A pharmaceutical composition, comprising a therapeutically effective concentration or amount of a modified FVII polypeptide of claim 1 in a pharmaceutically acceptable vehicle.

### Claim 11 (depends on 10)

A method, comprising treating a subject by administering the pharmaceutical composition of claim 10 to the subject, wherein the subject has a disease or condition that is treated by administration of FVII or a pro-coagulant.

### Claim 12 (depends on 11)

The method of claim 11, wherein the disease or condition is treated by administration of a zymogen or active form of FVII.

### Claim 13 (depends on 12)

The method of any of claims 12, wherein the disease or condition to be treated is selected from among blood coagulation disorders, hematologic disorders, hemorrhagic disorders, hemophilias, factor VII deficiency, bleeding disorders, surgical bleeding, or bleeding resulting from trauma.

### Claim 14 (depends on 1)

A nucleic acid molecule, comprising a sequence of nucleotides encoding a modified FVII polypeptide of claim 1.

### Claim 15 (depends on 14)

A vector, comprising the nucleic acid molecule of claim 14.

### Claim 16 (depends on 15)

The vector of claim 15, wherein the vector is a prokaryotic vector, viral vector or a eukaryotic vector.

### Claim 17 (depends on 15)

The vector of claim 15, wherein the vector is a mammalian vector or a yeast vector.

### Claim 18 (depends on 16)

The vector of claim 16, wherein the vector is selected from among an adenovirus, an adeno-associated-virus, a retrovirus, a herpes virus, a lentivirus, a poxvirus, a cytomegalovirus and Pichia.

### Claim 19 (depends on 15)

A cell, comprising the vector of claim 15.

### Claim 20 (depends on 19)

The cell of claim 19 that is a mammalian or yeast cell.

### Claim 21 (depends on 20)

The cell of claim 20, wherein the cell is selected from among a baby hamster kidney cell (BHK-21), a 293 cell, a CHO cell or a Pichia cell.

### Claim 22 (depends on 19)

The cell of claim 19, wherein the cell expresses the modified FVII polypeptide.

### Claim 23

A modified factor VII (FVII) polypeptide, comprising a modification in a FVII polypeptide, allelic or species variant thereof or active fragments thereof, selected from among amino acid modifications corresponding to D 196R, D 196Y, D196F, D196W, D196L, D196I, K197Y, K197E, K197D, K197L, K197M, K197M, K197I, K197V, K197F, K197W, K199D, K199E, G237W, G237I, G237V, R290M, R290V, K341M, K341D, G237T238insA, G237T238insS, G237T238insV, G237T238insAS, G237T238insSA, D196K197insK, D196K197insR, D196K197insY, D196K197insW, D196K197insA, D196K197insM, K1971198insE, K1971198insY, K1971198insA or K1971198insS in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3 or in corresponding residues in a FVII polypeptide.

### Claim 24 (depends on 23)

The modified FVII polypeptide of claim 23, comprising a further modification at another position in the FVII polypeptide.

### Claim 25 (depends on 24)

The modified FVII polypeptide of claim 24, wherein the further modification is an amino acid replacement, insertion or deletion.

### Claim 26 (depends on 23)

The modified FVII polypeptide of claim 23, wherein the further modification is one or more of an amino acid replacement at a position corresponding to a position selected from among D196, K197, K199, G237, T239, R290 and K341, wherein the further modification is in a different position from the first modification.

### Claim 27 (depends on 25)

The modified FVII polypeptide of claim 25, wherein the further amino acid modification is selected from among D196K, D196R, D196A, D196Y, D196F, D196M, D196W, D196L, D196I, K197Y, K197A, K197E, K197D, K197L, K197M, K197I, K197V, K197F, K197W, K199A, K199D, K199E, G237W, G237T, G237I, G237V, T239A, R290A, R290E, R290D, R290N, R290Q, R290K, K341E, K341R, K341N, K341M, K341D, and K341Q.

### Claim 28 (depends on 26)

The modified FVII polypeptide of claim 26, comprising modifications selected from among D196R/R290E, D196R/R290D, D196R/K197E/K199E, D196K/K197E/K199E, D196R/K197E/K199E/R290E, D196R/K197M/K199E, D196R/K197M/K199E/R290E, D196K/K197L, D196F/K197L, D196L/K197L, D196M/K197L, D196W/K197L, D196F/K197E, D196W/K197E, K197L/K341Q, G237V/K341Q, K197E/G237V/K341Q, K197E/K199E, K197E/G237V, K199E/K341Q, K197E/K199E/K341Q and K196V/K197E.

### Claim 29 (depends on 23)

A pharmaceutical composition, comprising a therapeutically effective concentration or amount of a modified FVII polypeptide of claim 23 in a pharmaceutically acceptable vehicle.

### Claim 30 (depends on 29)

A method, comprising treating a subject by administering the pharmaceutical composition of claim 29 to the subject, wherein the subject has a disease or condition that is treated by administration of FVII or a pro-coagulant.

### Claim 31 (depends on 30)

The method of claim 30, wherein the disease or condition is treated by administration of a zymogen or active form of FVII.

### Claim 32 (depends on 31)

The method of any of claims 31, wherein the disease or condition to be treated is selected from among blood coagulation disorders, hematologic disorders, hemorrhagic disorders, hemophilias, factor VII deficiency, bleeding disorders, surgical bleeding, or bleeding resulting from trauma.

### Claim 33 (depends on 23)

A nucleic acid molecule, comprising a sequence of nucleotides encoding a modified FVII polypeptide of claim 23.

### Claim 34 (depends on 33)

A vector, comprising the nucleic acid molecule of claim 33.

### Claim 35 (depends on 34)

The vector of claim 34, wherein the vector is a prokaryotic vector, viral vector or a eukaryotic vector.

### Claim 36 (depends on 34)

The vector of claim 34, wherein the vector is a mammalian vector or a yeast vector.

### Claim 37 (depends on 35)

The vector of claim 35, wherein the vector is selected from among an adenovirus, an adeno-associated-virus, a retrovirus, a herpes virus, a lentivirus, a poxvirus, a cytomegalovirus and Pichia.

### Claim 38 (depends on 34)

A cell, comprising the vector of claim 34.

### Claim 39 (depends on 38)

The cell of claim 38 that is a mammalian or yeast cell.

### Claim 40 (depends on 39)

The cell of claim 39, wherein the cell is selected from among a baby hamster kidney cell (BHK-21), a 293 cell, a CHO cell or a Pichia cell.

### Claim 41 (depends on 38)

The cell of claim 38, wherein the cell expresses the modified FVII polypeptide.

### Claim 42

A modified factor VII (FVII) polypeptide, comprising two or more modifications in a FVII polypeptide, allelic and species variant thereof or active fragments thereof, wherein:
the two or more amino acid modifications are selected from among amino acid modifications corresponding to D196K, D196R, D196A, D196Y, D196F, D196M, D196W, D196L, D196I, K197Y, K197A, K197E, K197D, K197L, K197M, K197I, K197V, K197F, K197W, K199A, K199D, K199E, G237W, G237T, G237I, G237V, T239A, R290A, R290E, R290D, R290N, R290Q, R290K, K341E, K341R, K341N, K341M, K341D, K341Q, G237T238insA, G237T238insS, G237T238insV, G237T238insAS, G237T238insSA, D196K197insK, D196K197insR, D196K197insY, D196K197insW, D196K197insA, D196K197insM, K1971198insE, K1971198insY, K1971198insA or K1971198insS in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3 or in corresponding residues in a FVII polypeptide.

### Claim 43 (depends on 15)

The modified FVII polypeptide of claim 15, wherein the FVII polypeptide contains 2, 3, 4, 5, 6 or 7 modifications.

### Claim 44 (depends on 15)

The modified FVII polypeptide of claim 15, comprising modifications selected from among D196R/R290E, D196K/R290E, D196R/R290D, D196R/K197E/K199E, D196K/K197E/K199E, D196R/K197E/K199E/R290E, D196R/K197M/K199E, D196R/K197M/K199E/R290E, D196K/K197L, D196F/K197L, D196L/K197L, D196M/K197L, D196W/K197L, D196F/K197E, D196W/K197E, D196V/K197E, K197E/K341Q, K197L/K341Q, G237V/K341Q, K197E/G237V/K341Q, K197E/K199E, K197E/G237V, K199E/K341Q, K197E/K199E/K341Q and K197E/G237V/M298Q.

### Claim 45 (depends on 42)

The modified FVII polypeptide of claim 42 that exhibits increased resistance to tissue factor pathway inhibitor (TFPI) compared with the unmodified FVII polypeptide.

### Claim 46 (depends on 42)

A pharmaceutical composition, comprising a therapeutically effective concentration or amount of a modified FVII polypeptide of claim 42 in a pharmaceutically acceptable vehicle.

### Claim 47 (depends on 46)

A method, comprising treating a subject by administering the pharmaceutical composition of claim 46 to the subject, wherein the subject has a disease or condition that is treated by administration of FVII or a pro-coagulant.

### Claim 48 (depends on 47)

The method of claim 47, wherein the disease or condition is treated by administration of a zymogen or active form of FVII.

### Claim 49 (depends on 48)

The method of any of claims 48, wherein the disease or condition to be treated is selected from among blood coagulation disorders, hematologic disorders, hemorrhagic disorders, hemophilias, factor VII deficiency, bleeding disorders, surgical bleeding, or bleeding resulting from trauma.

### Claim 50 (depends on 42)

A nucleic acid molecule, comprising a sequence of nucleotides encoding a modified FVII polypeptide of claim 42.

### Claim 51 (depends on 50)

A vector, comprising the nucleic acid molecule of claim 50.

### Claim 52 (depends on 51)

The vector of claim 51, wherein the vector is a prokaryotic vector, viral vector or a eukaryotic vector.

### Claim 53 (depends on 51)

The vector of claim 51, wherein the vector is a mammalian vector or a yeast vector.

### Claim 54 (depends on 52)

The vector of claim 52, wherein the vector is selected from among an adenovirus, an adeno-associated-virus, a retrovirus, a herpes virus, a lentivirus, a poxvirus, a cytomegalovirus and Pichia.

### Claim 55 (depends on 51)

A cell, comprising the vector of claim 51.

### Claim 56 (depends on 55)

The cell of claim 55 that is a mammalian or yeast cell.

### Claim 57 (depends on 56)

The cell of claim 56, wherein the cell is selected from among a baby hamster kidney cell (BHK-21), a 293 cell, a CHO cell or a Pichia cell.

### Claim 58 (depends on 55)

The cell of claim 55, wherein the cell expresses the modified FVII polypeptide.

### Claim 59 (depends on 1)

The modified FVII polypeptide of claim 1, further comprising a heterologous Gla domain, or a sufficient portion thereof to effect phospholipid binding by the heterologous Gla domain.

### Claim 60 (depends on 23)

The modified FVII polypeptide of claim 23, further comprising a heterologous Gla domain, or a sufficient portion thereof to effect phospholipid binding by the heterologous Gla domain.

### Claim 61 (depends on 42)

The modified FVII polypeptide of claim 42, further comprising a heterologous Gla domain, or a sufficient portion thereof to effect phospholipid binding by the heterologous Gla domain.

### Claim 62

A modified factor VII (FVII) polypeptide, comprising a heterologous Gla domain, or a sufficient portion thereof to effect phospholipid binding.

### Claim 63 (depends on 62)

The modified FVII polypeptide of claim 62, wherein the sufficient portion includes 30%, 40%, 50%, 60%, 70%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or more of the heterologous Gla domain.

### Claim 64 (depends on 62)

The modified FVII polypeptide of claim 62, wherein the heterologous Gla domain is selected from among a Gla domain in Factor IX (FIX), Factor X (FX), prothrombin, protein C, protein S, osteocalcin, matrix Gla protein, Growth-arrest-specific protein 6 (Gas6) and protein Z.

### Claim 65 (depends on 62)

The modified FVII polypeptide of claim 62, wherein the heterologous Gla domain has a sequence of amino acids set forth in any of SEQ ID NOS: 110-118, 120 and 121, or a sufficient portion thereof to effect phospholipid binding.

### Claim 66 (depends on 62)

The modified FVII polypeptide of claim 62, wherein all or a contiguous portion of the native FVII Gla domain is removed and is replaced with the heterologous Gla domain, or a sufficient portion thereof to effect phospholipid binding.

### Claim 67 (depends on 66)

The modified FVII polypeptide of claim 66, wherein the native FVII Gla domain includes amino acids 1-45 in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3, or in corresponding residues in a FVII polypeptide.

### Claim 68 (depends on 66)

The modified FVII polypeptide of claim 66, comprising a modification selected from among Gla Swap FIX, Gla Swap FX, Gla Swap Prot C, Gla Swap Prot S, Gla Swap Thrombin.

### Claim 69 (depends on 62)

The modified FVII polypeptide of claim 62, wherein:
the modified FVII polypeptide contains further modifications to exhibit increased resistance to tissue factor pathway inhibitor (TFPI) compared to a unmodified FVII polypeptide that does not include the further modifications.

### Claim 70 (depends on 69)

The modified FVII polypeptide of claim 69, wherein the further modifications are one or more amino acid modification(s) at positions selected from among D196, K197, K199, G237, T239, R290, and K341 in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3 or in corresponding residues in a FVII polypeptide.

### Claim 71 (depends on 70)

The modified FVII polypeptide of claim 70, wherein the one or more amino acid modification(s) are selected from among D196K, D196R, D196A, D196Y, D196F, D196M, D196W, D196L, D196I, K197Y, K197A, K197E, K197D, K197L, K197M, K197I, K197V, K197F, K197W, K199A, K199D, K199E, G237W, G237T, G237I, G237V, T239A, R290A, R290E, R290D, R290N, R290Q, R290K, K341E, K341R, K341N, K341M, K341D, K341Q, G237T238insA, G237T238insS, G237T238insV, G237T238insAS, G237T238insSA, D196K197insK, D196K197insR, D196K197insY, D196K197insW, D196K197insA, D196K197insM, K1971198insE, K1971198insY, K1971198insA and K1971198insS.

### Claim 72 (depends on 71)

The modified FVII polypeptide of claim 71, wherein the one or more amino acid modification(s) are selected from among D196R/R290E, D196K/R290E, D196R/R290D, D196R/K197E/K199E, D196K/K197E/K199E, D196R/K197E/K199E/R290E, D196R/K197M/K199E, and D196R/K197M/K199E/R290E.

### Claim 73 (depends on 1)

The modified FVII polypeptide claim 1, comprising one or more further amino acid modification(s) at position Q176, M298 or E296 in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3 or in corresponding residues in a FVII polypeptide.

### Claim 74 (depends on 73)

The modified FVII polypeptide of claim 73, wherein the amino acid modifications are selected from among Q176A, M298Q, E296V and E296A.

### Claim 75 (depends on 74)

The modified FVII polypeptide of claim 74, comprising amino acid modifications selected from among V158D/G237V/E296V/M298Q, K197E/G237V/M298Q, K197E/G237V/M298Q/K341Q, K197E/K199E/G237V/M298Q/K341Q, G237V/M298Q, G237V/M298Q/K341Q, M298Q/Gla Swap FIX, K197E/M298Q and M298Q/K341D.

### Claim 76 (depends on 23)

The modified FVII polypeptide claim 23, comprising one or more further amino acid modification(s) at position Q176, M298 or E296 in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3 or in corresponding residues in a FVII polypeptide.

### Claim 77 (depends on 76)

The modified FVII polypeptide of claim 76, wherein the amino acid modifications are selected from among Q176A, M298Q, E296V and E296A.

### Claim 78 (depends on 77)

The modified FVII polypeptide of claim 77, comprising amino acid modifications selected from among V158D/G237V/E296V/M298Q, K197E/G237V/M298Q, K197E/G237V/M298Q/K341Q, K197E/K199E/G237V/M298Q/K341Q, G237V/M298Q, G237V/M298Q/K341Q, M298Q/Gla Swap FIX, K197E/M298Q and M298Q/K341D.

### Claim 79 (depends on 42)

The modified FVII polypeptide claim 42, comprising one or more further amino acid modification(s) at position Q176, M298 or E296 in a FVII polypeptide having a sequence of amino acids set forth in SEQ ID NO:3 or in corresponding residues in a FVII polypeptide.

### Claim 80 (depends on 79)

The modified FVII polypeptide of claim 79, wherein the amino acid modifications are selected from among Q176A, M298Q, E296V and E296A.

### Claim 81 (depends on 80)

The modified FVII polypeptide of claim 80, comprising amino acid modifications selected from among V158D/G237V/E296V/M298Q, K197E/G237V/M298Q, K197E/G237V/M298Q/K341Q, K197E/K199E/G237V/M298Q/K341Q, G237V/M298Q, G237V/M298Q/K341Q, M298Q/Gla Swap FIX, K197E/M298Q and M298Q/K341D.

### Claim 82 (depends on 1)

The modified FVII polypeptide of claim 1, comprising one or more further amino acid modification(s) selected from among S278C/V302C, L279C/N301C, V280C/V301C, S281C/V299C, insertion of a tyrosine at position 4, F4S, F4T, P10Q, P10E, P10D, P10N, Q21N, R28F, R28E, I30C, I30D, I30E, K32D, K32Q, K32E, K32G, K32H, K32T, K32C, K32A, K32S, D33C, D33F, D33E, D33K, A34C, A34E, A34D, A34I, A34L, A34M, A34V, A34F, A34W, A34Y, R36D, R36E, T37C, T37D, T37E, K38C, K38E, K38T, K38D, K38L, K38G, K38A, K38S, K38N, K38H, L39E, L39Q, L39H, W41N, W41C, W41E, W41D, I42R, I42N, I42S, I42A, I42Q, I42N, I42S, I42A, I42Q, I42K, S43Q, S43N, Y44K, Y44C, Y44D, Y44E, S45C, S45D, S45E, D46C, A51N, S53N, G58N, G59S, G59T, K62E, K62R, K62D, K62N, K62Q, K62T, L65Q, L65S, L65N, F71D, F71Y, F71E, F71Q, F71N, P74S, P74A, A75E, A75D, E77A, E82Q, E82N, E82S, E82T T83K, N95S, N95T, G97S, G97T, Y101N, D104N, T106N, K109N, E116D, G117N, G124N, S126N, T128N, L141C, L141D, L141E, E142D, E142C, K143C, K143D, K143E, R144E, R144C, R144D, N145Y, N145G, N145F, N145M, N145S, N145I, N145L, N145T, N145V, N145P, N145K, N145H, N145Q, N145E, N145R, N145W, N145D, N145C, K157V, K157L, K157I, K157M, K157F, K157W, K157P, K157G, K157S, K157T, K157C, K157Y, K157N, K157E, K157R, K157H, K157D, K157Q, V158L, V158I, V158M, V158F, V158W, V158P, V158G, V158S, V158T, V158C, V158Y, V158N, V158E, V158R, V158K, V158H, V158D, V158Q, A175S, A175T, G179N, I186S, I186T, V188N, R202S, R202T, I205S, I205T, D212N, E220N, I230N, P231N, P236N, G237N, Q250C, V253N, E265N, T267N, E270N, A274M, A274L, A274K, A274R, A274D, A274V, A274I, A274F, A274W, A274P, A274G, A274T, A274C, A274Y, A274N, A274E, A274H, A274S, A274Q, F275H, R277N, F278S, F278A, F278N, F278Q, F278G, L280N, L288K, L288C, L288D, D289C, D289K, L288E, R290C, R290G, R290A, R290S, R290T, R290K, R290D, R290E, G291E, G291D, G291C, G291N, G291K, A292C, A292K, A292D, A292E, T293K, E296V, E296L, E296I, E296M, E296F, E296W, E296P, E296G, E296S, E296T, E296C, E296Y, E296N, E296K, E296R, E296H, E296D, E296Q, M298Q, M298V, M298L, M298I, M298F, M298W, M298P, M298G, M298S, M298T, M298C, M298Y, M298N, M298K, M298R, M298H, M298E, M298D, P303S, P303ST, R304Y, R304F, R304L, R304M, R304G, R304T, R304A, R304S, R304N, L305V, L305Y, L305I, L305F, L305A, L305M, L305W, L305P, L305G, L305S, L305T, L305C, L305N, L305E, L305K, L305R, L305H, L305D, L305Q, M306D, M306N, D309S, D309T, Q312N, Q313K, Q313D, Q313E, S314A, S314V, S314I, S314M, S314F, S314W, S314P, S314G, S314L, S314T, S314C, S314Y, S314N, S314E, S314K, S314R, S314H, S314D, S314Q, R315K, R315G, R315A, R315S, R315T, R315Q, R315C, R315D, R315E, K316D, K316C, K316E, V317C, V317K, V317D, V317E, G318N, N322Y, N322G, N322F, N322M, N322S, N322I, N322L, N322T, N322V, N322P, N322K, N322H, N322Q, N322E, N322R, N322W, N322C, G331N, Y332S, Y332A, Y332N, Y332Q, Y332G, D334G, D334E, D334A, D334V, D334I, D334M, D334F, D334W, D334P, D334L, D334T, D334C, D334Y, D334N, D334K, D334R, D334H, D334S, D334Q, S336G, S336E, S336A, S336V, S336I, S336M, S336F, S336W, S336P, S336L, S336T, S336C, S336Y, S336N, S336K, S336R, S336H, S336D, S336Q, K337L, K337V, K337I, K337M, K337F, K337W, K337P, K337G, K337S, K337T, K337C, K337Y, K337N, K337E, K337R, K337H, K337D, K337Q, K341E, K341Q, K341G, K341T, K341A, K341S, G342N, H348N, R353N, Y357N, I361N, F374P, F374A, F374V, F374I, F374L, F374M, F374W, F374G, F374S, F374T, F374C, F374Y, F374N, F374E, F374K, F374R, F374H, F374D, F374Q, V376N, R379N, L390C, L390K, L390D, L390E, M391D, M391C, M391K, M391N, M391E, R392C, R392D, R392E, S393D, S393C, S393K, S393E, E394K, P395K, E394C, P395D, P395C, P395E, R396K, R396C, R396D, R396E, P397D, P397K, P397C, P397E, G398K, G398C, G398D, G398E, V399C, V399D, V399K, V399E, L400K, L401K, L401C, L401D, L401E, R402D, R402C, R402K, R402E, A403K, A403C, A403D, A403E, P404E, P404D, P404C, P404K, F405K, P406C, K32N/A34S, K32N/A34T, F31N/D33S, F31N/D33T, 130N/K32S, 130N/K32T, A34N/R36S, A34N/R36T, K38N/F40S, K38N/F40T, T37N/L39S, T37N/L39T, R36N/K38S, R36N/K38T, L39N/W41S, L39N/W41T, F40N/142S, F40N/142T, I42N/Y44S, I42N/Y44T, Y44N/D46S, Y44N/D46T, D46N/D48S, D46N/D48T, G47N/Q49S, G47N/Q49T, K143N/N145S, K143N/N145T, E142N/R144S, E142N/R144T, L141N/K143S, L141N/K143T, I140N/E142S/, I140N/E142T, R144N/A146S, R144N/A146T, A146N/K148S, A146N/K148T, S147N/P149S/, S147N/P149T, R290N/A292S, R290N/A292T, D289N/G291S, D289N/G291T, L288N/R290S, L288N/R290T, L287N/D289S, L287N/D289, A292N/A294S, A292N/A294T, T293N/L295S, T293N/L295T, R315N/V317S, R315N/V317T, S314N/K316S, S314N/K316T, Q313N/R315S, Q313N/R315T, K316N/G318S, K316N/G318T, V317N/D319S, V317N/D319T, K341N/D343S, K341N/D343T, S339N/K341S, S339N/K341T, D343N/G345S, D343N/G345T, R392N/E394S, R392N/E394T, L390N/R392S, L390N/R392T, K389N/M391S, K389N/M391T, S393N/P395S, S393N/P395T, E394N/R396S, E394N/R396T, P395N/P397S, P395N/P397T, R396N/G398S, R396N/G398T, P397N/V399S, P397N/V399T, G398N/L400S, G398N/L400T, V399N/L401S, V399N/L401T, L400N/R402S, L400N/R402T, L401N/A403S, L401N/A403T, R402N/P404S, R402N/P404T, A403N/F405S, A403N/F405T, P404N/P406S and P404N/P406T.

### Claim 83 (depends on 23)

The modified FVII polypeptide of claim 23, comprising one or more further amino acid modification(s) selected from among S278C/V302C, L279C/N301C, V280C/V301C, S281C/V299C, insertion of a tyrosine at position 4, F4S, F4T, P10Q, P10E, P10D, P10N, Q21N, R28F, R28E, I30C, I30D, I30E, K32D, K32Q, K32E, K32G, K32H, K32T, K32C, K32A, K32S, D33C, D33F, D33E, D33K, A34C, A34E, A34D, A34I, A34L, A34M, A34V, A34F, A34W, A34Y, R36D, R36E, T37C, T37D, T37E, K38C, K38E, K38T, K38D, K38L, K38G, K38A, K38S, K38N, K38H, L39E, L39Q, L39H, W41N, W41C, W41E, W41D, I42R, I42N, I42S, I42A, I42Q, I42N, 142S, I42A, I42Q, I42K, S43Q, S43N, Y44K, Y44C, Y44D, Y44E, S45C, S45D, S45E, D46C, A51N, S53N, G58N, G59S, G59T, K62E, K62R, K62D, K62N, K62Q, K62T, L65Q, L65S, L65N, F71D, F71Y, F71E, F71Q, F71N, P74S, P74A, A75E, A75D, E77A, E82Q, E82N, E82S, E82T T83K, N95S, N95T, G97S, G97T, Y101N, D104N, T106N, K109N, E116D, G117N, G124N, S126N, T128N, L141C, L141D, L141E, E142D, E142C, K143C, K143D, K143E, R144E, R144C, R144D, N145Y, N145G, N145F, N145M, N145S, N145I, N145L, N145T, N145V, N145P, N145K, N145H, N145Q, N145E, N145R, N145W, N145D, N145C, K157V, K157L, K157I, K157M, K157F, K157W, K157P, K157G, K157S, K157T, K157C, K157Y, K157N, K157E, K157R, K157H, K157D, K157Q, V158L, V158I, V158M, V158F, V158W, V158P, V158G, V158S, V158T, V158C, V158Y, V158N, V158E, V158R, V158K, V158H, V158D, V158Q, A175S, A175T, G179N, I186S, I186T, V188N, R202S, R202T, I205S, I205T, D212N, E220N, I230N, P231N, P236N, G237N, Q250C, V253N, E265N, T267N, E270N, A274M, A274L, A274K, A274R, A274D, A274V, A274I, A274F, A274W, A274P, A274G, A274T, A274C, A274Y, A274N, A274E, A274H, A274S, A274Q, F275H, R277N, F278S, F278A, F278N, F278Q, F278G, L280N, L288K, L288C, L288D, D289C, D289K, L288E, R290C, R290G, R290A, R290S, R290T, R290K, R290D, R290E, G291E, G291D, G291C, G291N, G291K, A292C, A292K, A292D, A292E, T293K, E296V, E296L, E296I, E296M, E296F, E296W, E296P, E296G, E296S, E296T, E296C, E296Y, E296N, E296K, E296R, E296H, E296D, E296Q, M298Q, M298V, M298L, M298I, M298F, M298W, M298P, M298G, M298S, M298T, M298C, M298Y, M298N, M298K, M298R, M298H, M298E, M298D, P303S, P303ST, R304Y, R304F, R304L, R304M, R304G, R304T, R304A, R304S, R304N, L305V, L305Y, L305I, L305F, L305A, L305M, L305W, L305P, L305G, L305S, L305T, L305C, L305N, L305E, L305K, L305R, L305H, L305D, L305Q, M306D, M306N, D309S, D309T, Q312N, Q313K, Q313D, Q313E, S314A, S314V, S314I, S314M, S314F, S314W, S314P, S314G, S314L, S314T, S314C, S314Y, S314N, S314E, S314K, S314R, S314H, S314D, S314Q, R315K, R315G, R315A, R315S, R315T, R315Q, R315C, R315D, R315E, K316D, K316C, K316E, V317C, V317K, V317D, V317E, G318N, N322Y, N322G, N322F, N322M, N322S, N322I, N322L, N322T, N322V, N322P, N322K, N322H, N322Q, N322E, N322R, N322W, N322C, G331N, Y332S, Y332A, Y332N, Y332Q, Y332G, D334G, D334E, D334A, D334V, D334I, D334M, D334F, D334W, D334P, D334L, D334T, D334C, D334Y, D334N, D334K, D334R, D334H, D334S, D334Q, S336G, S336E, S336A, S336V, S336I, S336M, S336F, S336W, S336P, S336L, S336T, S336C, S336Y, S336N, S336K, S336R, S336H, S336D, S336Q, K337L, K337V, K337I, K337M, K337F, K337W, K337P, K337G, K337S, K337T, K337C, K337Y, K337N, K337E, K337R, K337H, K337D, K337Q, K341E, K341Q, K341G, K341T, K341A, K341S, G342N, H348N, R353N, Y357N, I361N, F374P, F374A, F374V, F374I, F374L, F374M, F374W, F374G, F374S, F374T, F374C, F374Y, F374N, F374E, F374K, F374R, F374H, F374D, F374Q, V376N, R379N, L390C, L390K, L390D, L390E, M391D, M391C, M391K, M391N, M391E, R392C, R392D, R392E, S393D, S393C, S393K, S393E, E394K, P395K, E394C, P395D, P395C, P395E, R396K, R396C, R396D, R396E, P397D, P397K, P397C, P397E, G398K, G398C, G398D, G398E, V399C, V399D, V399K, V399E, L400K, L401K, L401C, L401D, L401E, R402D, R402C, R402K, R402E, A403K, A403C, A403D, A403E, P404E, P404D, P404C, P404K, F405K, P406C, K32N/A34S, K32N/A34T, F31N/D33S, F31N/D33T, 130N/K32S, 130N/K32T, A34N/R36S, A34N/R36T, K38N/F40S, K38N/F40T, T37N/L39S, T37N/L39T, R36N/K38S, R36N/K38T, L39N/W41S, L39N/W41T, F40N/142S, F40N/142T, I42N/Y44S, I42N/Y44T, Y44N/D46S, Y44N/D46T, D46N/D48S, D46N/D48T, G47N/Q49S, G47N/Q49T, K143N/N145S, K143N/N145T, E142N/R144S, E142N/R144T, L141N/K143S, L141N/K143T, I140N/E142S/, I140N/E142T, R144N/A146S, R144N/A146T, A146N/K148S, A146N/K148T, S147N/P149S/, S147N/P149T, R290N/A292S, R290N/A292T, D289N/G291S, D289N/G291T, L288N/R290S, L288N/R290T, L287N/D289S, L287N/D289, A292N/A294S, A292N/A294T, T293N/L295S, T293N/L295T, R315N/V317S, R315N/V317T, S314N/K316S, S314N/K316T, Q313N/R315S, Q313N/R315T, K316N/G318S, K316N/G318T, V317N/D319S, V317N/D319T, K341N/D343S, K341N/D343T, S339N/K341S, S339N/K341T, D343N/G345S, D343N/G345T, R392N/E394S, R392N/E394T, L390N/R392S, L390N/R392T, K389N/M391S, K389N/M391T, S393N/P395S, S393N/P395T, E394N/R396S, E394N/R396T, P395N/P397S, P395N/P397T, R396N/G398S, R396N/G398T, P397N/V399S, P397N/V399T, G398N/L400S, G398N/L400T, V399N/L401S, V399N/L401T, L400N/R402S, L400N/R402T, L401N/A403S, L401N/A403T, R402N/P404S, R402N/P404T, A403N/F405S, A403N/F405T, P404N/P406S and P404N/P406T.

### Claim 84 (depends on 42)

The modified FVII polypeptide of claim 42, comprising one or more further amino acid modification(s) selected from among S278C/V302C, L279C/N301C, V280C/V301C, S281C/V299C, insertion of a tyrosine at position 4, F4S, F4T, P10Q, P10E, P10D, P10N, Q21N, R28F, R28E, I30C, I30D, I30E, K32D, K32Q, K32E, K32G, K32H, K32T, K32C, K32A, K32S, D33C, D33F, D33E, D33K, A34C, A34E, A34D, A34I, A34L, A34M, A34V, A34F, A34W, A34Y, R36D, R36E, T37C, T37D, T37E, K38C, K38E, K38T, K38D, K38L, K38G, K38A, K38S, K38N, K38H, L39E, L39Q, L39H, W41N, W41C, W41E, W41D, I42R, I42N, I42S, I42A, I42Q, I42N, 142S, I42A, I42Q, I42K, S43Q, S43N, Y44K, Y44C, Y44D, Y44E, S45C, S45D, S45E, D46C, A51N, S53N, G58N, G59S, G59T, K62E, K62R, K62D, K62N, K62Q, K62T, L65Q, L65S, L65N, F71D, F71Y, F71E, F71Q, F71N, P74S, P74A, A75E, A75D, E77A, E82Q, E82N, E82S, E82T T83K, N95S, N95T, G97S, G97T, Y101N, D104N, T106N, K109N, E116D, G117N, G124N, S126N, T128N, L141C, L141D, L141E, E142D, E142C, K143C, K143D, K143E, R144E, R144C, R144D, N145Y, N145G, N145F, N145M, N145S, N145I, N145L, N145T, N145V, N145P, N145K, N145H, N145Q, N145E, N145R, N145W, N145D, N145C, K157V, K157L, K157I, K157M, K157F, K157W, K157P, K157G, K157S, K157T, K157C, K157Y, K157N, K157E, K157R, K157H, K157D, K157Q, V158L, V158I, V158M, V158F, V158W, V158P, V158G, V158S, V158T, V158C, V158Y, V158N, V158E, V158R, V158K, V158H, V158D, V158Q, A175S, A175T, G179N, I186S, I186T, V188N, R202S, R202T, I205S, I205T, D212N, E220N, I230N, P231N, P236N, G237N, Q250C, V253N, E265N, T267N, E270N, A274M, A274L, A274K, A274R, A274D, A274V, A274I, A274F, A274W, A274P, A274G, A274T, A274C, A274Y, A274N, A274E, A274H, A274S, A274Q, F275H, R277N, F278S, F278A, F278N, F278Q, F278G, L280N, L288K, L288C, L288D, D289C, D289K, L288E, R290C, R290G, R290A, R290S, R290T, R290K, R290D, R290E, G291E, G291D, G291C, G291N, G291K, A292C, A292K, A292D, A292E, T293K, E296V, E296L, E296I, E296M, E296F, E296W, E296P, E296G, E296S, E296T, E296C, E296Y, E296N, E296K, E296R, E296H, E296D, E296Q, M298Q, M298V, M298L, M298I, M298F, M298W, M298P, M298G, M298S, M298T, M298C, M298Y, M298N, M298K, M298R, M298H, M298E, M298D, P303S, P303ST, R304Y, R304F, R304L, R304M, R304G, R304T, R304A, R304S, R304N, L305V, L305Y, L305I, L305F, L305A, L305M, L305W, L305P, L305G, L305S, L305T, L305C, L305N, L305E, L305K, L305R, L305H, L305D, L305Q, M306D, M306N, D309S, D309T, Q312N, Q313K, Q313D, Q313E, S314A, S314V, S314I, S314M, S314F, S314W, S314P, S314G, S314L, S314T, S314C, S314Y, S314N, S314E, S314K, S314R, S314H, S314D, S314Q, R315K, R315G, R315A, R315S, R315T, R315Q, R315C, R315D, R315E, K316D, K316C, K316E, V317C, V317K, V317D, V317E, G318N, N322Y, N322G, N322F, N322M, N322S, N322I, N322L, N322T, N322V, N322P, N322K, N322H, N322Q, N322E, N322R, N322W, N322C, G331N, Y332S, Y332A, Y332N, Y332Q, Y332G, D334G, D334E, D334A, D334V, D334I, D334M, D334F, D334W, D334P, D334L, D334T, D334C, D334Y, D334N, D334K, D334R, D334H, D334S, D334Q, S336G, S336E, S336A, S336V, S336I, S336M, S336F, S336W, S336P, S336L, S336T, S336C, S336Y, S336N, S336K, S336R, S336H, S336D, S336Q, K337L, K337V, K337I, K337M, K337F, K337W, K337P, K337G, K337S, K337T, K337C, K337Y, K337N, K337E, K337R, K337H, K337D, K337Q, K341E, K341Q, K341G, K341T, K341A, K341S, G342N, H348N, R353N, Y357N, 1361N, F374P, F374A, F374V, F374I, F374L, F374M, F374W, F374G, F374S, F374T, F374C, F374Y, F374N, F374E, F374K, F374R, F374H, F374D, F374Q, V376N, R379N, L390C, L390K, L390D, L390E, M391D, M391C, M391K, M391N, M391E, R392C, R392D, R392E, S393D, S393C, S393K, S393E, E394K, P395K, E394C, P395D, P395C, P395E, R396K, R396C, R396D, R396E, P397D, P397K, P397C, P397E, G398K, G398C, G398D, G398E, V399C, V399D, V399K, V399E, L400K, L401K, L401C, L401D, L401E, R402D, R402C, R402K, R402E, A403K, A403C, A403D, A403E, P404E, P404D, P404C, P404K, F405K, P406C, K32N/A34S, K32N/A34T, F31N/D33S, F31N/D33T, 130N/K32S, 130N/K32T, A34N/R36S, A34N/R36T, K38N/F40S, K38N/F40T, T37N/L39S, T37N/L39T, R36N/K38S, R36N/K38T, L39N/W41S, L39N/W41T, F40N/142S, F40N/142T, I42N/Y44S, I42N/Y44T, Y44N/D46S, Y44N/D46T, D46N/D48S, D46N/D48T, G47N/Q49S, G47N/Q49T, K143N/N145S, K143N/N145T, E142N/R144S, E142N/R144T, L141N/K143S, L141N/K143T, I140N/E142S/, I140N/E142T, R144N/A146S, R144N/A146T, A146N/K148S, A146N/K148T, S147N/P149S/, S147N/P149T, R290N/A292S, R290N/A292T, D289N/G291S, D289N/G291T, L288N/R290S, L288N/R290T, L287N/D289S, L287N/D289, A292N/A294S, A292N/A294T, T293N/L295S, T293N/L295T, R315N/V317S, R315N/V317T, S314N/K316S, S314N/K316T, Q313N/R315S, Q313N/R315T, K316N/G318S, K316N/G318T, V317N/D319S, V317N/D319T, K341N/D343S, K341N/D343T, S339N/K341S, S339N/K341T, D343N/G345S, D343N/G345T, R392N/E394S, R392N/E394T, L390N/R392S, L390N/R392T, K389N/M391S, K389N/M391T, S393N/P395S, S393N/P395T, E394N/R396S, E394N/R396T, P395N/P397S, P395N/P397T, R396N/G398S, R396N/G398T, P397N/V399S, P397N/V399T, G398N/L400S, G398N/L400T, V399N/L401S, V399N/L401T, L400N/R402S, L400N/R402T, L401N/A403S, L401N/A403T, R402N/P404S, R402N/P404T, A403N/F405S, A403N/F405T, P404N/P406S and P404N/P406T.

### Claim 85 (depends on 1)

The modified FVII polypeptide of claim 1, comprising substitution of positions 300-322, 305-322, 300-312, or 305-312 with the corresponding amino acids from trypsin, thrombin or FX, or substitution of positions 310-329, 311-322 or 233-329 with the corresponding amino acids from trypsin.

### Claim 86 (depends on 23)

The modified FVII polypeptide of claim 23, comprising substitution of positions 300-322, 305-322, 300-312, or 305-312 with the corresponding amino acids from trypsin, thrombin or FX, or substitution of positions 310-329, 311-322 or 233-329 with the corresponding amino acids from trypsin.

### Claim 87 (depends on 42)

The modified FVII polypeptide of claim 42, comprising substitution of positions 300-322, 305-322, 300-312, or 305-312 with the corresponding amino acids from trypsin, thrombin or FX, or substitution of positions 310-329, 311-322 or 233-329 with the corresponding amino acids from trypsin.

### Claim 88 (depends on 1)

The modified FVII polypeptide of claim 1, wherein the unmodified FVII polypeptide has a sequence of amino acids set forth in SEQ ID NO:3.

### Claim 89 (depends on 23)

The modified FVII polypeptide of claim 23, wherein the unmodified FVII polypeptide has a sequence of amino acids set forth in SEQ ID NO:3.

### Claim 90 (depends on 42)

The modified FVII polypeptide of claim 42, wherein the unmodified FVII polypeptide has a sequence of amino acids set forth in SEQ ID NO:3.

### Claim 91

The modified FVII polypeptide, comprising a sequence of amino acids residues whose sequence is forth in any of SEQ ID NOS: 18-43 and 125-146 and 206-250.

### Claim 92 (depends on 91)

A modified FVII polypeptide that is an allelic or species variant thereof or that has at least 80%, 85%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or more sequence identity with a polypeptide of claim 91.

### Claim 93 (depends on 1)

A modified FVII polypeptide of claim 1, wherein the polypeptide:
is a single-chain polypeptide or is a two-chain or multiple-chain polypeptide; and/or
is active or activated.

### Claim 94 (depends on 23)

A modified FVII polypeptide of claim 23, wherein the polypeptide:
is a single-chain polypeptide or is a two-chain or multiple-chain polypeptide; and/or
is active or activated.

### Claim 95 (depends on 42)

A modified FVII polypeptide of claim 42, wherein the polypeptide:
is a single-chain polypeptide or is a two-chain or multiple-chain polypeptide; and/or
is active or activated.

### Claim 96 (depends on 62)

A modified FVII polypeptide of claim 62, wherein the polypeptide:
is a single-chain polypeptide or is a two-chain or multiple-chain polypeptide; and/or
is active or activated.

### Claim 97 (depends on 1)

The modified polypeptide of claim 1, wherein the coagulation activity is increased compared to the absence of the modification.

### Claim 98 (depends on 23)

The modified polypeptide of claim 23, wherein the coagulation activity is increased compared to the absence of the modification.

### Claim 99 (depends on 42)

The modified polypeptide of claim 42, wherein the coagulation activity is increased compared to the absence of the modification.

### Claim 100 (depends on 62)

The modified polypeptide of claim 62, wherein the coagulation activity is increased compared to the absence of the modification.
